Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Director's Dealing 2020

Dec 23, 2020

65122_rns_2020-12-23_404a8242-45a4-49d0-8f17-357b6627a10c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity IMMUTEP LIMITED (ASX: IMM)
ABN 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Russell John Howard
Date of last notice 9 December 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Russell J Howard Pty Ltd < Russell J HowardA/C>
Date of change 24 December 2020
No. of securities held prior to change 1. 500,000 ordinary shares2. 500,000 performance rights
Class Ordinary shares
Number acquired 250,000 ordinary shares
Number disposed 250,000 performance rights
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation NilThe Performance Rights were issued in lieuof additional cash to compensate Dr HowardforhisadditionalresponsibilitiesasChairman of the Company in accordancewith the shareholder approval obtained at theAnnual General Meeting held on 16November 2018.No amount is payable upon exercise of thePerformance Rights for shares after vesting.
No. of securities held after change 1. 750,000 Fully Paid Ordinary Shares2. 250,000 Director Performance Rights
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back Vesting and exercise of 3rd tranche ofPerformance Rights out of the 1,000,000Performance Rights (post share consolidationbasis) approved for Dr Russell John Howardat AGM on 16 November 2018.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above No
traded during a+closed period where prior written clearance
was required?
If so, was prior written clearance provided to allow the trade to N/A
proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3